Recent News:

GeoVax Labs Reports 2013 First Quarter Financial Results and Provides Clinical Development Update
in Financial - 05/02/2013

GeoVax Labs Reports 2012 Financial Results and Progress
in Financial - 03/11/2013

GeoVax Labs Launches New Corporate Website
in General - 01/23/2013

GeoVax Labs Releases Update Letter to Shareholders
in General - 01/15/2013

GeoVax Announces Enrollment Completion for Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
in General - 01/10/2013

GeoVax Announces Full Enrollment of Phase 1 Clinical Trial for 2nd Generation HIV/AIDS Vaccine
in General - 12/18/2012

GeoVax Featured in Five Publications
in Press - 12/13/2012

More News:

GeoVax Labs to Present at Fifth Annual LD Micro Conference
in Events - 11/29/2012

GeoVax Reports 2012 Third Quarter Financial Results
in Financial - 11/14/2012

GeoVax Labs to Present at the 11th Annual BIO Investor Forum
in Events - 10/05/2012

GeoVax Awarded 1.9 Million USD Grant by US Government for HIV/AIDS Vaccine Program
in Financial - 10/01/2012

GeoVax HIV/AIDS Vaccines Featured in Four Presentations at 2012 Global AIDS Vaccine Conference
in Events - 09/26/2012

GeoVax to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
in Events - 09/04/2012

GeoVax Reports 2012 Second Quarter Final Results
in Financial - 08/13/2012

GeoVax to Present at the SeeThruEquity Microcap Investor Forum July 18 in New York City
in Events - 07/12/2012

GeoVax to Attend BIO International Convention June 18-21 in Boston
in Events - 06/11/2012

HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV
in General - 05/22/2012